Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.35 |
| ▸ | CA12 | O43570 | 6/20 | 0.35 |
| ▸ | CA1 | P00915 | 6/20 | 0.35 |
| ▸ | CA4 | P22748 | 6/20 | 0.35 |
| ▸ | CA9 | Q16790 | 6/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 6/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | GLP1R | P43220 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25696350 | 0.88 | EPHX2 (0.36) | CA2CA12CA1CA4CA9 | |
| SCHEMBL31697409 | 0.88 | EPHX2 (0.36) | CA2CA12CA1CA4CA9 | |
| SCHEMBL25701620 | 0.87 | CA2 (0.34) | CA2CA12CA1CA4CA9 | |
| SCHEMBL31697400 | 0.84 | TLR2 (0.36) | CA2CA12CA1CA4CA9 | |
| SCHEMBL31217941 | 0.84 | TLR2 (0.36) | CA2CA12CA1CA4CA9 | |
| SCHEMBL31697519 | 0.82 | TLR2 (0.33) | — | |
| SCHEMBL23193205 | 0.81 | GLP1R (0.32) | GLP1R | |
| SCHEMBL31756758 | 0.80 | GLP1R (0.35) | SMN1; SMN2MEN1KMT2AGLP1R | |
| SCHEMBL22618814 | 0.80 | FFAR1 (0.32) | — | |
| SCHEMBL22618750 | 0.79 | FAAH (0.36) | TSHREPHX2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748843-A2 | ANTIBODY-DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Medilink Therapeutics (Suzhou) Co., Ltd. (CN) | 2026-05-27 | — | — | EP | disclosed |
| EP-4552654-A1 | ANTIBODY-DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Medilink Therapeutics (Suzhou) Co., Ltd. (CN) | 2025-05-14 | — | — | EP | disclosed |